Hawaii Cancer Care
Hawaii Cancer Care is a community oncology practice providing hematology and medical oncology services — including chemotherapy, immunotherapy, BiTE and PROVENGE therapy, clinical trials, and in-house lab and specialty pharmacy — through three clinics on Oahu and Maui, serving Hawaii cancer patients as a partner practice of American Oncology Network.
- Company typePrivate
- Founded2003
- HeadquartersHonolulu, United States
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Hawaii Cancer Care does
Hawaii Cancer Care is a private community oncology practice headquartered in Honolulu, Hawaii, specializing in hematology and medical oncology services across the state. The practice operates three clinic locations — Honolulu (Waterfront Plaza), Aiea (Westridge Center), and a newly opened Kahului, Maui clinic (December 2025) — staffed by four board-certified medical oncologists and hematologists (Drs. Palalay, Tamura, Yee, Fukumoto) and supported by four or more advanced practitioners and a registered oncology dietitian. Service lines span chemotherapy, immunotherapy, targeted therapy, hormonal therapy, biological therapy, radiation therapy, hematology care, and advanced treatments including BiTE therapy and PROVENGE immunotherapy, complemented by clinical trial access, in-house laboratory, in-house specialty pharmacy with 24/7 assistance, telehealth, and supportive services (financial counseling, care coordination, survivorship care, CanCare emotional support, and the Empowered Healing wellness program). The practice treats 100+ cancer types and hematologic conditions and serves patients across Oahu and Maui who would otherwise need to travel to the mainland for care.
Hawaii Cancer Care has been operating for more than 20 years and in April 2024 became a partner practice of American Oncology Network (AON, Nasdaq: AONC), a national alliance of 300+ oncology providers across 20 states. The AON affiliation provides access to clinical trials, BiTE therapy rollout, revenue-diversifying ancillary services, and operational infrastructure while the practice maintains its own clinical team and brand. Revenue is generated through fee-for-service patient care billed to insurance plans and patients, in-house specialty pharmacy dispensing, telehealth consultations, and financial counseling/patient assistance services. Patient acquisition is driven by physician referrals, direct patient intake, second-opinion consultations, and content marketing via the practice website and blog. Hawaii Cancer Care is described as the only multi-location cancer care provider in the state, anchoring its distribution advantage in Hawaii's geographically isolated healthcare market.
Hawaii Cancer Care firmographics
Firmographics- Name
- Hawaii Cancer Care
- Legal name
- Hawaii Cancer Care
- Website
- https://hawaiicancercare.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Hawaii Cancer Care is a community oncology practice providing hematology and medical oncology services — including chemotherapy, immunotherapy, BiTE and PROVENGE therapy, clinical trials, and in-house lab and specialty pharmacy — through three clinics on Oahu and Maui, serving Hawaii cancer patients as a partner practice of American Oncology Network.
- Ownership category
- akta.pro rank
Hawaii Cancer Care industry classification
Industry- Product category
- Oncology and Hematology Care Services
- NAICS
- Offices of Physicians (62111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Medical Oncology (HLAKAFAB)
- akta.pro secondary industries
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Radiation Oncology (HLAKAFAC)
Keywords
Where Hawaii Cancer Care is headquartered
LocationHeadquarters
- HQ city
- Honolulu
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Hawaii Cancer Care business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Patient Care Services: Revenue generated from comprehensive cancer treatment services including chemotherapy, immunotherapy, targeted therapy, hematology treatments, and related medical services billed to patients and insurance providers.
- Specialty Pharmacy: In-house specialty pharmacy providing oral cancer medications with dispensing and delivery services, generating revenue from medication dispensing.
- Financial Counseling and Patient Assistance: Financial counseling services including patient assistance programs, payment plans, and help exploring financial assistance options such as grants and co-pay assistance programs.
- Telehealth Services: Virtual visit services charged according to insurance coverage, with patients paying usual copay/deductible or telehealth patient fee.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Pay-as-you-go | Insurance-based billing with copays, deductibles, and co-insurance |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Hawaii Cancer Care product offering
Product offeringCore offering
Hawaii Cancer Care is a community oncology practice providing hematology and medical oncology services across Hawaii through three clinic locations in Honolulu, Aiea, and Kahului. Core offerings include chemotherapy, immunotherapy, targeted therapy, BiTE therapy, PROVENGE immunotherapy, clinical trial access, and in-house laboratory and specialty pharmacy services for patients with solid tumors, blood cancers, and hematologic disorders.
Product overview
Hawaii Cancer Care is a community oncology practice offering comprehensive cancer and blood disorder treatment across Hawaii through three locations (Honolulu, Aiea, and Kahului). The practice provides a unified suite of services centered around Medical Oncology and Hematology as core offerings, supplemented by specialized treatments including BiTE Therapy and PROVENGE immunotherapy. Treatment modalities span chemotherapy (oral, IV, injection, direct placement), radiation therapy, targeted therapy, hormonal therapy, and biological therapy. The practice integrates clinical trial access, in-house laboratory and specialty pharmacy, care coordination, survivorship care, and telehealth. Support services include financial counseling, oncology dietitian services, CanCare emotional support, and the Empowered Healing wellness program. All services are delivered by board-certified medical oncologists and hematologists using a multidisciplinary, precision-based approach close to patients' homes.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Oncology Cancer treatment using chemotherapy, biological agents, targeted therapies, immunotherapy, and oral chemotherapy administered by board-certified medical oncologists for patients diagnosed with solid tumors and blood-based cancers.
- Hematology Diagnosis and treatment of blood cancers, hematologic malignancies, and autoimmune disorders including lymphoma, leukemia, myelodysplastic syndromes, multiple myeloma, and aplastic anemia.
- BiTE Therapy Bispecific antibody therapy that links T cells to cancer cells to boost immune response with precision targeting for blood cancers and solid tumors.
- Chemotherapy Personalized, precision-based chemotherapy delivered orally, intravenously, via direct placement, or by injection, administered by experienced oncology physicians with proactive side effect management.
- Radiation Therapy High-energy ray treatment to damage or kill cancer cells, offered as external beam radiation or internal brachytherapy.
- Targeted Therapy Cancer treatment designed to specifically target cancer cells while minimizing damage to normal, healthy cells.
- Hormonal Therapy Hormone-based cancer treatment, particularly effective for hormone receptor-positive breast cancer.
- Biological Therapy Immune system-based treatment including interferon, interleukin, monoclonal antibodies, cytokines, and vaccines.
- PROVENGE Treatment FDA-approved sipuleucel-T immunotherapy for men with advanced metastatic castrate-resistant prostate cancer (mCRPC), reprogramming the immune system to target and attack prostate cancer cells.
- Clinical Trials Program Clinical trial programs enabling patients to participate in approved and exploratory cancer therapies without long-distance travel, monitored by research doctors and oncology experts.
- Care Coordination & Navigation Comprehensive care coordination including symptom monitoring, medication education, nutritional guidance, barrier identification, and personalized care planning throughout the treatment journey.
- CanCare Support Free emotional support program connecting patients and families with trained volunteer cancer survivors and caregivers matched to their specific situation.
- Empowered Healing Program Holistic, evidence-based wellness program with six pillars: nutrition, movement, stress management, sleep, hydration, and support system to enhance outcomes and quality of life during and after treatment.
- Financial Support Services Financial counseling including insurance review, cost estimation, payment plans, and patient assistance programs for managing cancer treatment costs.
- In-House Laboratory In-house laboratory performing all routine blood work for convenient and timely diagnostic services integrated with oncology care.
- In-House Specialty Pharmacy Specialty pharmacy providing convenient dispensing and delivery of oral cancer drugs with 24/7 pharmacy assistance.
- Oncology Dietitian Services Registered dietitian specializing in oncology nutrition to help patients identify nutrition goals and plan dietary approaches during treatment and recovery.
- Telehealth Services Virtual video consultations enabling patients to meet with physicians and care team from home or any private location using computer or mobile device.
- Online Bill Payment Secure online bill payment system available 24/7 allowing patients to view balances, make payments via credit/debit card, Apple Pay, or check, and set up payment plans.
Quantifiable outcome
- Patients can receive comprehensive cancer treatment without traveling long distances, reducing logistical and financial barriers to care
- +1 more outcomes
Companies that use Hawaii Cancer Care
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles2 records
Hawaii Cancer Care technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
Feature6 records
Hawaii Cancer Care partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- American Oncology Network (AON)coreHawaii Cancer Care is a partner practice of American Oncology Network (AON), a national alliance of physicians and healthcare leaders. The partnership provides Hawaii Cancer Care with additional resources and support to continue their patient-first care approach. AON offers comprehensive support including integrated revenue-diversifying ancillary services, practice management expertise, and access to clinical trials and advanced therapies like BiTE therapy across AON's network of over 300 providers practicing across 20 states.
Scale indicators5 records
Recent moves8 records
Expansion highlights6 records
Hawaii Cancer Care competitors and assessment
Company assessmentDirect peers
- American Oncology Network: Parent alliance (Nasdaq: AONC) and direct peer to Hawaii Cancer Care as a community oncology practice network spanning 20+ states. Operates a hub-and-spoke model of partner practices with shared clinical trials, ancillary services, and specialty drug programs—the same template HCC operates within.
- US Oncology Network (McKesson): One of the largest community oncology networks in the US, owned by McKesson. Comparable as a physician-led community oncology platform offering clinical trials, technology, and operational support to affiliated practices.
- The Oncology Institute: Public community oncology practice (NASDAQ: TOI) offering medical oncology, hematology, and infusion services across multiple states. Closely comparable in care model (community-based, multi-specialty oncology, ancillary services) and serves as a useful valuation comparable.
- OneOncology: National partnership of community oncology practices providing practice management, technology, and clinical trial infrastructure. Comparable business model to AON and therefore a direct peer to Hawaii Cancer Care at the network level.
Broad incumbents
- Stanford Cancer Institute: NCI-designated comprehensive cancer center that serves as a referral destination for complex cases from the Pacific region including Hawaii. Indirect competitor for high-acuity cases that may leave the islands.
- Sarah Cannon Cancer Institute (HCA): Hospital-based cancer program within HCA Healthcare offering community oncology services and clinical trials across a large national footprint. Comparable in offering clinical trial access and community-based oncology, but operates inside a much larger hospital network.
- City of Hope: Major NCI-designated cancer center with national footprint (including acquired Cancer Treatment Centers of America sites). Represents the mainland academic destination for complex oncology cases that may bypass Hawaii community providers.
Regional players
- Pacific Cancer Foundation of Hawaii: Hawaii-based nonprofit supporting cancer patients on Maui and across the state through financial assistance and navigation services. Adjacent ecosystem participant that partners with providers like Hawaii Cancer Care for patient support.
- Queen's Medical Center (Queen's Cancer Center): Largest hospital system in Hawaii with a comprehensive cancer center including medical oncology, radiation oncology, and surgical oncology. Direct local competitor in Honolulu for cancer referrals and a key reason HCC's multi-island strategy matters.
- Hawaii Pacific Health: Multi-hospital system in Hawaii (Straub, Kapiolani, Pali Momi, Wilcox) providing oncology services across the islands. Competes with HCC for community oncology referrals and represents the integrated delivery network threat in the local market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Hawaii Cancer Care social profiles
Digital presenceHawaii Cancer Care financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hawaii Cancer Care leadership team
Management profileNumber of profiles
Profiles9 records
Hawaii Cancer Care funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hawaii Cancer Care M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hawaii Cancer Care
What does Hawaii Cancer Care do?
Hawaii Cancer Care is a community oncology practice providing hematology and medical oncology services across Hawaii through three clinic locations in Honolulu, Aiea, and Kahului. Core offerings include chemotherapy, immunotherapy, targeted therapy, BiTE therapy, PROVENGE immunotherapy, clinical trial access, and in-house laboratory and specialty pharmacy services for patients with solid tumors, blood cancers, and hematologic disorders.
Is Hawaii Cancer Care a public or private company?
Hawaii Cancer Care is a private company. It is classified as corporate owned and is currently operating.
When was Hawaii Cancer Care founded?
Hawaii Cancer Care was founded in 2003. It employs 51 to 100 people.
Where is Hawaii Cancer Care based?
Hawaii Cancer Care is headquartered in Honolulu, United States, in the North America region.
How does Hawaii Cancer Care make money?
Four revenue lines are on record. Patient Care Services are the primary driver. The others are specialty Pharmacy, financial Counseling and Patient Assistance and telehealth Services.
Who are Hawaii Cancer Care's main competitors?
Direct peers on record are American Oncology Network, US Oncology Network (McKesson), The Oncology Institute and OneOncology. Broad incumbents are Stanford Cancer Institute, Sarah Cannon Cancer Institute (HCA) and City of Hope. Regional players are Pacific Cancer Foundation of Hawaii, Queen's Medical Center (Queen's Cancer Center) and Hawaii Pacific Health.
Does Hawaii Cancer Care have an API?
No public API is recorded for Hawaii Cancer Care.
What industry is Hawaii Cancer Care in?
Hawaii Cancer Care's product category is Oncology and Hematology Care Services. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 62111 and its SIC code is 8011.